Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japan Issues Strong Warning Over Brexit

Executive Summary

Uncertainty is bad for business and can deter investment, warns Japan in relation to eventual talks on the UK’s exit from the EU. Japan’s preferred Brexit outcome? For the UK to keep both EU law and the European Medicines Agency.

Advertisement

Related Content

Pharma Firms Urged To Push For Post-Brexit Regulatory Equivalence Deal
EMA Post-Brexit: 'It Can’t Stay In The UK' … Or Can It?
Refocus, Optimize, Externalize: Takeda Overhauls Global R&D
Eisai Says Lenvatinib Lost in UK Market Access Maze Due To NICE Inaction
Daiichi Sankyo Shutting UK Site As Global Cost Drive Continues

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC097293

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel